Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Generic Priorities: McClellan Lays Out Ambitious Agenda At GPhA

Feb 03 2003

• By The Tan Sheet

Related Content

Waxman’s Generic Reform: No 30-Month Stay, Early Declaratory Judgements

Feb 03 2003

FDA Generics Review Staff To Increase 25% In President’s Budget Request

Jan 27 2003

FDA Patent Listing Criteria Allow Polymorph, Product-By-Process Claims

Oct 28 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window